Taking Stock of the Markets

Barbara Marcin is the Portfolio Manager of The Gabelli Dividend Growth Fund and The Gabelli Dividend & Income Trust.

The above webcast is an excerpt from a CNBC broadcast that appeared on May 30, 2012. The webcast is made available by CNBC and is provided on GAMCO's website for your convenience only.

GAMCO is providing these links as a matter of general information. We do not intend for these links to be a complete description of any security or company and it is not an offer or solicitation to buy or sell any security, nor is it a research report with respect to any of the companies mentioned herein.

As of April 30, 2012, affiliates of GAMCO Investors, Inc. beneficially owned less than 1% of Pfizer, Inc., E.I. du Pont de Nemours and Company, Monsanto Co. and Microsoft Corp. The Gabelli Dividend Growth Fund owned 24,490 shares of Pfizer Inc. (representing 2.26% of the fund), 12,000 shares of E.I. du Pont de Nemours and Company (2.58% of the fund), 1,000 shares of Monsanto Co. (less than 1% of the fund) and 18,000 shares of Microsoft Corp. (2.32% of the fund). The Gabelli Dividend & Income Trust owned 737,000 shares of Pfizer Inc. (representing less than 1% of the fund), 178,099 shares of E.I. du Pont de Nemours and Company (less than 1% of the fund) and 125,000 shares of Monsanto Co. (less than 1% of the fund). Individual securities mentioned are not representative of the entire portfolio.

The Portfolio Manager’s views are subject to change at any time based on market and other conditions. The information in this posting represents the opinions of the individual Portfolio Manager and is not intended to be a forecast of future events, a guarantee of future results, or investment advice. Views expressed are those of the Portfolio Managers and may differ from those of other portfolio managers or of the Firm as a whole. Because the portfolio managers at GAMCO and our affiliates make individual investment decisions with respect to the client accounts that they manage, these accounts may have transactions inconsistent with the information contained in this posting. These analysts may know the substance of the posting prior to its posting. GAMCO and its affiliates may receive compensation from the companies referenced herein or may be soliciting any company referenced herein as a client for their services.

Discussion of any particular security or performance of any particular fund by a CNBC commentator does not represent an offer of any product or service available from GAMCO Investors, Inc. and is not representative of any portfolio of any fund or account managed by the company.

This webcast is not an offer to sell any security nor is it a solicitation of an offer to buy any security.

The Gabelli Dividend & Income Trust is a closed end investment company whose shares trade on the NYSE and the value of such shares may trade at a discount to the net asset value.

The Fund's share price will fluctuate with changes in the market value of the Fund's portfolio securities. Stocks are subject to market, economic and business risks that cause their prices to fluctuate. When you sell Fund shares, they may be worth less than what you paid for them. Consequently, you can lose money be investing in the Fund.

Investors should carefully consider the investment objectives, risks, charges, and expenses of the fund before investing. The prospectus contains information about these and other matters and should be read carefully before investing.

For more information or a prospectus, visit our website at: www.gabelli.com or call: 800-GABELLI
800-422-3554 o 914-921-5100 o Fax: 914-921-5118 o info@gabelli.com
Distributed by Gabelli & Company, Inc. One Corporate Center, Rye, New York 10580